Traffic:
10E
10W
15N
15S
57N
57S
60E
60W
210E
210W
This Site
Web Search
powered by
YAHOO! SEARCH
Subscriber Services
|
Home Delivery
|
e-Edition
|
Alerts
|
RSS
Home
News
Ontario
Rancho Cucamonga
Pomona
Upland
Claremont
Montclair
Chino Valley
California
Crime & Public Safety
Elections
Education
S.B. County Watch
Upland Watch
I.E.: Medicare Testing Ground
Sports
Buy Event Tickets Now
Golf - Tee Times and Courses
Preps
Reign Hockey
Rancho Cucamonga Quakes
Local Colleges
USC
UCLA
Lakers
Clippers
Dodgers
Angels
Ducks
Soccer
Motor Sports
Horse Racing
Live Odds
Business
Autos
Real Estate News
Technology
Opinions
Editorial
Letters
Columnists
Blogs
LA.COM
Buy Tickets
Movies
TV
Music
Shopping & Beauty
Recreation
Neighborhood
Arts
Living
Dining
Find A Restaurant
Lottery
Horoscopes
Travel
Trevor's Travels
Health
Crossword Puzzle
Local Casinos
Foothills Magazine
Info
Subscribe For Home Delivery
Contact Us
RSS
Podcast
Subscriber Services
Place An Ad
NIE
Classified
Place an Ad
Homes
Jobs
Auto
Search autos
Buy/Sell a car
Research/Financing a car
Find a dealer
Shopping
This week's ads
Obits
Directories
Local Business
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Fate Therapeutics, Inc.
Fate Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates
August 13, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
August 02, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics Appoints Neely Mozaffarian, MD, PhD, FACR, to its Board of Directors
July 31, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
June 04, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics to Present at 2024 Jefferies Global Healthcare Conference
May 29, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
May 09, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program
May 09, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2024 Financial Results and Operational Updates
May 06, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting
May 03, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting
April 22, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference
April 03, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
April 02, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
March 19, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics to Present at Upcoming March Investor Conferences
March 01, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
February 26, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2023 Financial Results
February 15, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
February 02, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics Announces Initiation of Phase 1 Clinical Trial for FT825 / ONO-8250 in Patients with HER2-expressing Advanced Solid Tumors
January 08, 2024
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 13, 2023
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates
November 08, 2023
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2023 Financial Results
October 25, 2023
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics to Present at Upcoming September Investor Conferences
August 31, 2023
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates
August 08, 2023
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2023 Financial Results
July 28, 2023
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics to Present at Upcoming June Investor Conferences
May 31, 2023
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics Reports First Quarter 2023 Financial Results and Business Updates
May 03, 2023
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2023 Financial Results
April 24, 2023
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Fate Therapeutics to Present at Upcoming March Investor Conferences
March 03, 2023
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Privacy Policy
|
Terms of Use
|
MNG Corporate Site Map
|
Copyright